Licensing databases

PharmaPlus owns two licensing databases for early stage partnering and licensing deal benchmarking.

Unpublished Pharma Patent Applications database

This online database especially responds to the demand for early stage inventions of investors and pharmaceutical and biotechnology companies.
The database focuses on early stage life sciences inventions with unpublished patent applications, more particularly on biopharmaceutical products and technologies within 18 months after their patent filing or priority date.

Single point of worldwide search

We provide industry with a single point of search across a wide range of life sciences licensing opportunities for which a patent application has been filed but not yet has been published.
We actively source these unpublished early stage patent applications among the best universities and research organizations worldwide.
Our specific database provides non-profit research organizations a unique opportunity to promote and license their unpublished patent applications as soon as possible after patent filing.

Focus areas

The Unpublished Pharma Patent Applications database solely displays diagnostic, therapeutic, vaccines, animal models, research tools and platform technology licensing opportunities.
Each licensing opportunity presented in the database contains information on the invention background, development status, potential applications, IP position and full contact details.

Always up-to-date and under 18 months after filing

We continuously update our database and remove licensing opportunities older than 18 months after their patent filing or priority date. In addition we actively promote this unique database worldwide to potential investors and suitable collaboration partners who are looking for in-licensing opportunities.

Click here to visit the Unpublished Pharma Patent Applications database website.

Therapeutic licensing deal financials database

PharmaPlus owns a company-company deal financials database, which solely focuses on therapeutics licensing deals from 1996 until today. From this database PharmaPlus provides affordable customized company-company licensing deals database extracts.

A valuable intelligence tool for pharmaceutical and biotechnology companies to support their upcoming licensing deal negotiations and their presentations to potential investors.

Easy to read

  • Benchmark your partnering deal terms
  • Identify creative deal structures
  • Identify companies partnering in your interest area
  • Track competitor deal making activity
  • Access detailed financial information
  • Monitor deal trends in your areas of interest
  • Gain insight into how big pharma structure their licensing deals

The database solely displays licensing deals for which at least one financial component (potential deal size, upfront, milestones, royalties, equity, research funding) is available.

For enquiries into deal financials on specific indications, compound classes, development status at time of deal closure, territories or any other criteria of interest to you, we invite you to contact us to discuss your enquiry.
Our customized company-company deal financials extracts are provided at a minimum of 5 and a maximum of 25 licensing deals database.